Search

everythinglearnresearchcommunity

for

Search:↓

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Terbinafine can cause hair loss.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Young men with hair loss may have a higher risk of insulin resistance and related health issues.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Southern Chinese women with female pattern hair loss have less, thinner hair and smaller hair follicles.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Finasteride causes harmful organ changes in female mice.

Finger length ratios don't predict baldness in men.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

The Spanish Hair-Specific Skindex-29 questionnaire effectively measures the quality of life impact of hair loss in Spanish-speaking women.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

LLLT is a safe, promising hair loss treatment, but more research needed.

Older age and certain lifestyles are linked to thinner, weaker hair, while how you see your hair relates to its thickness.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.